Amiodarone--induced Changes in Surfactant Phospholipids of Rat Lung

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1993 Apr 1

PMID 8510769

Authors

B Padmavathy

H Devaraj

N Devaraj

Affiliations

Soon will be listed here.

Abstract

Amiodarone HCl (AD) is a very effective antiarrhythmic drug, but its use is often associated with serious pulmonary complications. It is shown to induce lung phospholipidosis. Nevertheless, the effects of this drug on pulmonary surfactant which is composed of about 75% phospholipids and which prevents alveolar collapse is not known. Therefore, we have examined the effect of AD on the intra- and extracellular surfactant pools and on the levels of phosphatidylcholine (PC), the primary constituent of pulmonary surfactant. Male Wistar rats were fed AD (175 mg/kg) by oral gavage for three weeks. At the end of the experimental period, the rats were killed, the lungs removed and perfused, and surfactant isolated. Some lungs were prepared for ultrastructural examination. Phospholipid was assayed in the intra- and extracellular surfactant. Amiodarone produced a significant increase in both the intra- and extracellular surfactant phospholipid along with an appreciable change in the phospholipid profile. Also, the drug seemed to increase the number of lamellar inclusions in the surfactant producing type II alveolar cells. These data suggest that administration of AD leads to an increase in the lung surfactant phospholipid levels and lamellar bodies in alveolar type II cells.

References

Wilson B, Jaworski A, Donner M, Lippmann M . Amiodarone-induced pulmonary toxicity in the rat. Lung. 1989; 167(5):301-11. DOI: 10.1007/BF02714959. View

Liu F, Cohen R, Downar E, Butany J, Edelson J, Rebuck A . Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax. 1986; 41(2):100-5. PMC: 460270. DOI: 10.1136/thx.41.2.100. View

Hostetler K, Giordano J, Jellison E . In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone. Biochim Biophys Acta. 1988; 959(3):316-21. DOI: 10.1016/0005-2760(88)90205-6. View

Kodavanti U, Mehendale H . Amiodarone- and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung. Am J Respir Cell Mol Biol. 1991; 4(4):369-78. DOI: 10.1165/ajrcmb/4.4.369. View

Reasor M . Drug-induced lipidosis and the alveolar macrophage. Toxicology. 1981; 20(1):1-33. DOI: 10.1016/0300-483x(81)90102-5. View

Miles P, Bowman L, Tucker J, Reasor M, Wright J . Alterations in rat alveolar surfactant phospholipids and proteins induced by administration of chlorphentermine. Biochim Biophys Acta. 1986; 877(1):167-78. DOI: 10.1016/0005-2760(86)90132-3. View

Singh B . Amiodarone: historical development and pharmacologic profile. Am Heart J. 1983; 106(4 Pt 2):788-97. DOI: 10.1016/0002-8703(83)90002-9. View

LULLMANN H, Lullmann-Rauch R, Wassermann O . Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol. 1978; 27(8):1103-8. DOI: 10.1016/0006-2952(78)90435-5. View

Hostetler K . Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs. Fed Proc. 1984; 43(11):2582-5. View

10.

Leibovich S, Ross R . A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol. 1976; 84(3):501-14. PMC: 2032522. View

11.

Kacew S . Role of phospholipase C in chlorphentermine-induced pulmonary phospholipidosis in rat. Proc Soc Exp Biol Med. 1988; 188(1):35-9. DOI: 10.3181/00379727-188-42703. View

12.

Carvajal R, Gonzalez R, Selman M . Cell-mediated immunity against connective tissue in experimental pulmonary fibrosis. Lung. 1982; 160(3):131-40. DOI: 10.1007/BF02719285. View

13.

Joshi U, Rao P, Kodavanti S, Lockard V, Mehendale H . Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis. Biochim Biophys Acta. 1989; 1004(3):309-20. DOI: 10.1016/0005-2760(89)90078-7. View

14.

Kodavanti U, Mehendale H . Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev. 1990; 42(4):327-54. View

15.

Hostetler K, Reasor M, Walker E, Yazaki P, Frazee B . Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats. Biochim Biophys Acta. 1986; 875(2):400-5. DOI: 10.1016/0005-2760(86)90192-x. View

16.

Martin W, Howard D . Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug. Am J Pathol. 1985; 120(3):344-50. PMC: 1887977. View

17.

Katyal S, Estes L, Lombardi B . Method for the isolation of surfactant from homogenates and lavages of lung of adult, newborn, and fetal rats. Lab Invest. 1977; 36(6):585-92. View

18.

van Zandwijk N, Darmanata J, Duren D, Alberts C, Durrer D, Wagenvoort C . Amiodarone pneumonitis. Eur J Respir Dis. 1983; 64(4):313-7. View

19.

Marchlinski F, Gansler T, Waxman H, Josephson M . Amiodarone pulmonary toxicity. Ann Intern Med. 1982; 97(6):839-45. DOI: 10.7326/0003-4819-97-6-839. View

20.

Dake M, Madison J, Montgomery C, Shellito J, Hinchcliffe W, Winkler M . Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. Am J Med. 1985; 78(3):506-12. DOI: 10.1016/0002-9343(85)90346-8. View